RU2004113194A -
METHOD FOR TREATING IRON DEFICIENCY ANEMIA
- Google Patents
METHOD FOR TREATING IRON DEFICIENCY ANEMIA
Download PDF
Info
Publication number
RU2004113194A
RU2004113194ARU2004113194/14ARU2004113194ARU2004113194ARU 2004113194 ARU2004113194 ARU 2004113194ARU 2004113194/14 ARU2004113194/14 ARU 2004113194/14ARU 2004113194 ARU2004113194 ARU 2004113194ARU 2004113194 ARU2004113194 ARU 2004113194A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Михаил Евгеньевич Зазнобов (RU), Михаил Евгеньевич Зазнобов, Рафик Галимз нович Сайфутдинов (RU), Рафик Галимзянович СайфутдиновfiledCriticalМихаил Евгеньевич Зазнобов (RU)
Priority to RU2004113194/14ApriorityCriticalpatent/RU2272641C2/en
Publication of RU2004113194ApublicationCriticalpatent/RU2004113194A/en
Application grantedgrantedCritical
Publication of RU2272641C2publicationCriticalpatent/RU2272641C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Claims (1)
Способ лечения железодефицитной анемии, включающий введение железосодержащего препарата, отличающийся тем, что дополнительно предварительно перорально вводят энтеросорбент, например, полифепан, в течение 10 дней от начала курса лечения в дозировке 5 мг 3 раза в день, затем продолжают лечение введением железосодержащего препарата.A method of treating iron deficiency anemia, comprising administering an iron-containing preparation, characterized in that an enterosorbent, for example, polyphepan, is additionally pre-orally administered for 10 days from the start of the treatment at a dosage of 5 mg 3 times a day, then treatment with the iron-containing preparation is continued.
RU2004113194/14A2004-04-282004-04-28Method for treatment of asiderotic anemia
RU2272641C2
(en)
PHARMACEUTICAL COMPOSITION THAT INCLUDES AN OLIGÓMERO-PHARMACO INSULIN CONJUGATE, METHOD TO TREAT INSULIN DEFICIENCY IN A SUBJECT, METHOD FOR PROVIDING A PHARMACEUTICAL COMPOSITION.